ivWatch Patient Monitoring System

ivWatch continuously monitors tissue adjacent to IV insertion sites,
providing early detection of infiltration/extravasation events using
proprietary monitors and sensors to reduce patient injury. In March, we
received FDA clearance to detect iron sucrose extravasations, the
leakage outside veins, which causes permanent irreversible skin
staining.

EluPro™

EluPro is the world’s first FDA cleared antibiotic-eluting BioEnvelope
that resolves common post-surgical device failures. It consists of a
natural biomaterial to stabilize medical devices and incorporates
rifampin and minocycline, which reduces the risk of bacterial
complications and addresses critical surgical complications.

Dual-Phase Hydrogel

Dual-Phase Hydrogel is a groundbreaking liquid biomaterial that becomes
gelatinous at body temperature. Administered via injection without open
surgery required, it prevents post-surgical adhesions and stimulates
cell growth to speed up recovery. This innovation is perfect for
treating lumbar laminectomy, knee osteoarthritis, and bone fracture.

Lingo

Lingo is a continuous glucose monitor available over the counter and
without a prescription. Lingo provides personal insights to help people
build healthy habits, retrain their metabolism & improve overall
well-being. The biosensor is worn for up to 14 days, streams data to the
Lingo app, translating the body’s responses to food, exercise &
stress.

Water N 4

The Water-N4 is a non-electric smart IoT bidet that generates power
through water pressure and installs easily on existing toilets. When
used, it automatically performs real-time feces analysis to detect
health abnormalities early. Users can check results instantly via the
app, helping to prevent progression of colorectal cancer and diseases.

iDose® TR

iDose TR is a first-of-its-kind anchored ocular micro-implant that
revolutionizes glaucoma management. iDose TR delivers continuous
long-term prostaglandin analog therapy directly into the eye for IOP
control with proven safety and patient tolerability.

Eversense 365®

Eversense 365 Continuous Glucose Monitoring System (CGM) is the world’s
first one-year CGM system. It is indicated for the management of type 1
and type 2 diabetes in people age 18+. It is the only CGM that provides
one year of accurate monitoring with minimal interruptions, helping
solve the everyday frustrations of traditional, short-term CGMs.

TriClip™ Transcatheter Edge-to-Edge Repair System

Abbott’s TriClip™ transcatheter edge-to-edge repair (TEER) system is a
first-of-its-kind, minimally invasive device purposefully designed for
the heart’s hard-to-treat tricuspid valve, offering a safe, effective
and non-surgical solution for patients suffering from severe tricuspid
regurgitation (TR).

NanoScopic™ Release System

The NanoScopic Release System revolutionizes endoscopic carpal tunnel
surgery by utilizing the NanoScope’s “chip on stick” technology. This
system provides the ability to negate costly OR equipment and greatly
improves the efficiencies and costs. Most importantly it can enable
office-based procedures greatly improving the patient post op recovery.

Esprit™ BTK System

Abbott’s Esprit™ BTK Everolimus Eluting Resorbable Scaffold System
(Esprit™ BTK System) is a groundbreaking and first-of-its-kind
dissolving stent that sets a new standard of care for individuals with
Peripheral Artery Disease (PAD), a condition that affects over 200
million people globally.

Ready for Nomination Season?

Complete the form below to download the 2027 Nomination Guide.

A Founders Guide to Modern Innovation
The Future of the Grid – Panel Discussion 2024 Edison Awards
Edison Award-Winning Brain Technology Featured in U.S. News & World Report